Apyx Medical Corporation (APYX) on Monday said it has submitted a new 510(k) premarket notification to the U.S. Food and Drug Administration seeking to expand the label of its AYON Body Contouring System to include power liposuction.
The AYON system, which is already FDA-cleared, integrates fat removal, tissue contraction, contouring, and electrosurgical functions in a single platform.
A 510(k) premarket notification is a submission to the FDA demonstrating that a new medical device is substantially equivalent to a legally marketed one.
"Upon receiving FDA clearance for power liposuction, we will be able to activate the new functionality in the AYON systems already installed at surgical centers across the U.S. through the ongoing commercial launch," said Charlie Goodwin, President and Chief Executive Officer.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.